(18)F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer

There is an unmet need for predictive biomarkers of the clinical benefit of antiangiogenic drugs. The aim of the present study was to prospectively evaluate the value of (18)F-FDG PET/CT performed during and after preoperative chemoradiotherapy with bevacizumab for the prediction of complete patholo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Nucl Med
Autors principals: Avallone, Antonio, Aloj, Luigi, Pecori, Biagio, Caracò, Corradina, De Stefano, Alfonso, Tatangelo, Fabiana, Silvestro, Lucrezia, Granata, Vincenza, Bianco, Francesco, Romano, Carmela, Di Gennaro, Francesca, Budillon, Alfredo, Petrillo, Antonella, Muto, Paolo, Botti, Gerardo, Delrio, Paolo, Lastoria, Secondo
Format: Artigo
Idioma:Inglês
Publicat: Society of Nuclear Medicine 2019
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6836863/
https://ncbi.nlm.nih.gov/pubmed/30877175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.222604
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars